Published: 12/08/2019
Premedication
Note: This forms part of the comprehensive pre-assessment of patients. It should be assessed as part of the overall pre-assessment process.
Learning outcome:
- To prescribe premedication when indicated, especially for the high risk population
Knowledge |
|---|
| Competence | Description | Assessment Methods | GMP |
|---|---|---|---|
| PD_BK_01 | Summarises the value of appropriate explanations and reassurance in alleviating the patient’s anxiety | A,C,E | 1,3 |
| PD_BK_02 | Lists basic indications for prescription of pre-medication | A,C,E | 1 |
| PD_BK_03 | Describes the rationale for the use of different anxiolytic and sedative drugs | A,C,E | 1 |
| PD_BK_04 | Discusses the applied pharmacology of sedative and anxiolytic drugs | A,C,E | 1 |
| PD_BK_05 | Recalls the factors that influence the risk of gastric reflux/aspiration and lists strategies to reduce it | A,C,D,E | 1,2 |
| PD_BK_06 | Explains the applied pharmacology of pro-kinetic and antacids including simple alkalis, H2 receptor antagonists and proton pump inhibitors | A,C,E | 2 |
| PD_BK_07 | Describes the application of local/national guidelines on management of thromboembolic risk | A,C,E | 1,2 |
Skills |
|---|
| Competence | Description | Assessment Methods | GMP |
|---|---|---|---|
| PD_BS_01 |
Prescribes appropriate agents to reduce the risk of regurgitation and aspiration |
A,C,D,E | 1,2 |
| PD_BS_02 |
Explains, in a way the patient understands, the benefits and possible risks of sedative premedication |
A,E,M | 3,4 |
| PD_BS_03 |
Prescribes appropriate anxiolytic/sedative premedication when indicated |
A,C,E | 1 |